Monika Tornsen
Director/Board Member at IMMUNIC, INC.
Profile
Monika Maria Tornsen is an Independent Director at Immunic, Inc. and President-North America at Calliditas Therapeutics AB.
She was previously Senior Vice President & General Manager-US at Sarepta Therapeutics, Inc., Vice President-Global Therapeutic at Genzyme Corp., and Chief Commercial Officer at Passage Bio, Inc. Tornsen is a graduate of the University of Lund.
Monika Tornsen active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNIC, INC. | Director/Board Member | 2022-07-04 |
| CALLIDITAS THERAPEUTICS AB | Corporate Officer/Principal | 2024-01-06 |
Former positions of Monika Tornsen
| Companies | Position | End |
|---|---|---|
| PASSAGE BIO, INC. | Corporate Officer/Principal | 2022-11-30 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 2020-12-31 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2018-12-31 |
Training of Monika Tornsen
| University of Lund | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| CALLIDITAS THERAPEUTICS AB | Health Technology |
| PASSAGE BIO, INC. | Health Technology |
| IMMUNIC, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Monika Tornsen
